456 related articles for article (PubMed ID: 25912273)
1. Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies.
Brookes RH; Ming M; Williams K; Hopfer R; Gurunathan S; Gallichan S; Tang M; Ochs MM
Hum Vaccin Immunother; 2015; 11(7):1836-9. PubMed ID: 25912273
[TBL] [Abstract][Full Text] [Related]
2. A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge.
Ochs MM; Williams K; Sheung A; Lheritier P; Visan L; Rouleau N; Proust E; de Montfort A; Tang M; Mari K; Hopfer R; Gallichan S; Brookes RH
Hum Vaccin Immunother; 2016 Nov; 12(11):2946-2952. PubMed ID: 27392182
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to PcpA and PhtD protect mice against Streptococcus pneumoniae by a macrophage- and complement-dependent mechanism.
Visan L; Rouleau N; Proust E; Peyrot L; Donadieu A; Ochs M
Hum Vaccin Immunother; 2018 Feb; 14(2):489-494. PubMed ID: 29135332
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine.
Bologa M; Kamtchoua T; Hopfer R; Sheng X; Hicks B; Bixler G; Hou V; Pehlic V; Yuan T; Gurunathan S
Vaccine; 2012 Dec; 30(52):7461-8. PubMed ID: 23123106
[TBL] [Abstract][Full Text] [Related]
5. Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children.
Ren D; Almudevar AL; Pichichero ME
Hum Vaccin Immunother; 2015; 11(2):489-97. PubMed ID: 25692218
[TBL] [Abstract][Full Text] [Related]
6. Combined protective effects of anti-PhtD and anti-pneumococcal polysaccharides.
Denoël P; Godfroid F; Hermand P; Verlant V; Poolman J
Vaccine; 2011 Sep; 29(38):6451-3. PubMed ID: 21315695
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of protective immunity responses against pneumococcal PhtD and its C-terminal in combination with outer-membrane vesicles as adjuvants.
Malekan M; Siadat SD; Aghasadeghi M; Shahrokhi N; Afrough P; Behrouzi A; Ahmadi K; Mousavi SF
J Med Microbiol; 2020 Mar; 69(3):465-477. PubMed ID: 32100705
[No Abstract] [Full Text] [Related]
8. Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model.
Verhoeven D; Xu Q; Pichichero ME
Vaccine; 2014 May; 32(26):3205-10. PubMed ID: 24731814
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults.
Seiberling M; Bologa M; Brookes R; Ochs M; Go K; Neveu D; Kamtchoua T; Lashley P; Yuan T; Gurunathan S
Vaccine; 2012 Dec; 30(52):7455-60. PubMed ID: 23131206
[TBL] [Abstract][Full Text] [Related]
10. Contributions to protection from Streptococcus pneumoniae infection using the monovalent recombinant protein vaccine candidates PcpA, PhtD, and PlyD1 in an infant murine model during challenge.
Verhoeven D; Perry S; Pichichero ME
Clin Vaccine Immunol; 2014 Aug; 21(8):1037-45. PubMed ID: 24850621
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials.
Leroux-Roels I; Devaster JM; Leroux-Roels G; Verlant V; Henckaerts I; Moris P; Hermand P; Van Belle P; Poolman JT; Vandepapelière P; Horsmans Y
Vaccine; 2015 Jan; 33(4):577-84. PubMed ID: 24176494
[TBL] [Abstract][Full Text] [Related]
12. Protection against Streptococcus pneumoniae Invasive Pathogenesis by a Protein-Based Vaccine Is Achieved by Suppression of Nasopharyngeal Bacterial Density during Influenza A Virus Coinfection.
Khan MN; Xu Q; Pichichero ME
Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895132
[TBL] [Abstract][Full Text] [Related]
13. Failure to elicit seroresponses to pneumococcal surface proteins (pneumococcal histidine triad D, pneumococcal choline-binding protein A, and serine proteinase precursor A) in children with pneumococcal bacteraemia.
Hagerman A; Posfay-Barbe KM; Grillet S; Ochs MM; Brookes RH; Greenberg D; Givon-Lavi N; Dagan R; Siegrist CA
Clin Microbiol Infect; 2012 Aug; 18(8):756-62. PubMed ID: 21851490
[TBL] [Abstract][Full Text] [Related]
14. Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model.
Xu Q; Pryharski K; Pichichero ME
Vaccine; 2017 Jan; 35(2):337-344. PubMed ID: 27919628
[TBL] [Abstract][Full Text] [Related]
15. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
[TBL] [Abstract][Full Text] [Related]
16. A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae.
Denoël P; Philipp MT; Doyle L; Martin D; Carletti G; Poolman JT
Vaccine; 2011 Jul; 29(33):5495-501. PubMed ID: 21624422
[TBL] [Abstract][Full Text] [Related]
17. Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization.
Moens L; Hermand P; Wellens T; Wuyts G; Derua R; Waelkens E; Ysebaert C; Godfroid F; Bossuyt X
Hum Vaccin Immunother; 2018 May; 14(5):1234-1242. PubMed ID: 29400602
[TBL] [Abstract][Full Text] [Related]
18. Human antibodies to PhtD, PcpA, and Ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae.
Kaur R; Surendran N; Ochs M; Pichichero ME
Infect Immun; 2014 Dec; 82(12):5069-75. PubMed ID: 25245804
[TBL] [Abstract][Full Text] [Related]
19. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
[TBL] [Abstract][Full Text] [Related]
20. Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2-4 years: A phase II randomized study.
Odutola A; Ota MO; Ogundare EO; Antonio M; Owiafe P; Worwui A; Greenwood B; Alderson M; Traskine M; Verlant V; Dobbelaere K; Borys D
Hum Vaccin Immunother; 2016; 12(2):393-402. PubMed ID: 26618243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
